We are live on
!
Find out more
SFP
Sterling Financial Planning Portfolio holdings
AUM
$337M
1-Year Est. Return
19.27%
This Fund
S&P 500
This Quarter
Est. Return
-1.48%
1 Year Est. Return
+19.27%
3 Year Est. Return
+46.75%
5 Year Est. Return
+48.15%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$3.12M
(+2%)
Cap. Flow
+$5.73M
Cap. Flow
% of AUM
3.65%
Top 10 Holdings %
Top 10 Hldgs %
47.46%
Holding
434
New
33
Increased
110
Reduced
60
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Gold Trust
IAU
|
+$564K |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$445K |
| 3 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$393K |
| 4 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$393K |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$333K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$304K |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$174K |
| 3 |
Meta Platforms (Facebook)
META
|
+$172K |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$133K |
| 5 |
LBAI
Lakeland Bancorp Inc
LBAI
|
+$99.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.08% |
| 2 | Financials | 2.79% |
| 3 | Healthcare | 2.73% |
| 4 | Industrials | 1.93% |
| 5 | Consumer Discretionary | 1.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG.RT
426
Bristol-Myers Squibb Rights
CELG.RT
$210M
| $0 | ﹤0.01% |
375
| – | – |
|
|
CGC
427
Canopy Growth
CGC
$410M
| – | – |
-18
| Closed | -$4K |
|
428
Delta Air Lines
DAL
$60B
| – | – |
-795
| Closed | -$34K |
|
429
NVIDIA
NVDA
$5.38T
| – | – |
-1,320
| Closed | -$26K |
|
430
Rackspace Technology
RXT
$1.23B
| – | – |
-700
| Closed | -$14K |
|
|
CDMO
431
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $0 | ﹤0.01% |
9
| – | – |
|
|
DRNA
432
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – |
-100
| Closed | -$4K |
|
|
KCAC
433
DELISTED
Kensington Capital Acquisition Corp. II
KCAC
| – | – |
-346
| Closed | -$10K |
|
|
ALXN
434
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-18
| Closed | -$3K |
|
Similar funds
NL
FIM
SIC
SC
SG
BCM
CAC
HFS
Sterling Financial Planning's Q3 2021 Portfolio in Review
As of Q3 2021, Sterling Financial Planning held 434 positions worth $157M, up 2% from $154M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Sterling Financial Planning deployed $5.73M of net new capital in Q3 2021, opening 33 new positions and adding to 110 existing holdings. Its largest new stake was Lam Research: 3,000 shares worth $171K.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $304K trimmed.
- Sterling Financial Planning's largest Q3 2021 buy was Lam Research: 3,000 shares worth $171K.
- Sterling Financial Planning added most to iShares Gold Trust in Q3 2021, an estimated $564K increase.
- Sterling Financial Planning's biggest Q3 2021 reduction was Pfizer, cutting an estimated $304K.
- Sterling Financial Planning fully exited Delta Air Lines in Q3 2021, selling an estimated $34K.
- Sterling Financial Planning's ten largest holdings make up 47% of its $157M portfolio in Q3 2021.
- Sterling Financial Planning opened 33 new positions and closed 7 in Q3 2021.
- Sterling Financial Planning's portfolio value rose 2% quarter-over-quarter to $157M.
Based on Sterling Financial Planning's 13F filing for Q3 2021, filed 28 Oct 2021.